Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service

Sbrana,Andrea; Paolieri,Federico; Bloise,Francesco; Danova,Marco; Galli,Luca; Brunetti,Isa M.; Vasile,Enrico; Ricci,Sergio; Falcone,Alfredo; Antonuzzo,Andrea

doi:10.3892/br.2020.1274

April-2020 Volume 12 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

April-2020 Volume 12 Issue 4

Full Size Image

Article

Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service

Authors:
- Andrea Sbrana
- Federico Paolieri
- Francesco Bloise
- Marco Danova
- Luca Galli
- Isa M. Brunetti
- Enrico Vasile
- Sergio Ricci
- Alfredo Falcone
- Andrea Antonuzzo
View Affiliations / Copyright

Affiliations: Medical Oncology Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, I‑56126 Pisa, Italy, Internal Medicine and Medical Oncology, AZIENDA Socio‑Sanitaria Territoriale di Pavia, I‑27100 Pavia, Italy
Pages: 199-203
|
Published online on: February 10, 2020

https://doi.org/10.3892/br.2020.1274
Expand metrics +

Abstract

Patients with cancer may develop disease‑ or treatment‑associated anemia, requiring red blood product transfusions. In Italy, transfusions are usually administered in a day hospital service or in inpatient wards. Since 2013, a dedicated supportive care service for outpatients has been implemented in Pisa, where red blood product transfusions are administered. The present study evaluated the patients that received red blood product transfusions at the dedicated supportive care service for outpatients in 2016. The clinical features of patients were analyzed, and the procedural cost was evaluated by comparing its administration with a hypothetical scenario in which transfusions were provided via day hospital services or inpatient wards. The results revealed that the dedicated supportive care service for outpatients avoided the hospitalization of patients, allowing them to receive prompt and timely transfusions, with a rapid resolution of symptoms. Avoiding hospitalization was also estimated to decrease transfusion‑associated costs by €48,805‑177,805.

View Figures

View References

1	Macciò A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC, Floris C, Omoto I, Barracca A and Ganz T: The role of inflammation, iron, and nutritional status in cancer-related anemia: Results of a large, prospective, observational study. Haematologica. 100:124–132. 2015.PubMed/NCBI View Article : Google Scholar
2	Steegman JL, Sánchez Torres JM, Colomer R, Vaz Á, López J, Jalón I, Provencio M, González-Martín A and Pérez M: Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: A Spanish survey. Clin Transl Oncol. 15:477–483. 2013.PubMed/NCBI View Article : Google Scholar
3	Knight K, Wade S and Balducci L: Prevalence and outcomes of anemia in cancer: A systematic review of literature. Am J Med. 116 (Suppl 7A):11S–26S. 2004.PubMed/NCBI View Article : Google Scholar
4	Schrijvers D, De Samblanx H and Roila F: ESMO Guidelines Working Group: Erythropoiesis-stimulating agents in the treatment of anemia in cancer patients: ESMO clinical practice guidelines for use. Ann Oncol. 21:v244–v247. 2010.PubMed/NCBI View Article : Google Scholar
5	Schwartz RN: Anemia in patients with cancer: Incidence, causes, impact, management, and use of treatment guidelines and protocols. Am J Health Syst Pharm. 64 (Suppl 2):S5–S13. 2007.PubMed/NCBI View Article : Google Scholar
6	National Cancer Institute National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0; NIH publication #09-7473. Published May 28, 2009; Revised Version 4.03 Jun 14, 2010.
7	Henry D and Dahl N: Iron or vitamin B12 deficiency in anemic cancer patients prior to erythropoiesis stimulating agent therapy. Community Oncol. 4:351–356. 2007. View Article : Google Scholar
8	Rodgers GM III, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, Coccia PF, Djulbegovic B, Gilreath JA, Kraut EH, et al: Cancer- and chemotherapy-induced anemia. J Natl Compr Canc Netw. 10:628–653. 2012.PubMed/NCBI View Article : Google Scholar
9	Spivak JL, Gascon P and Ludwig H: Anemia management in oncology and hematology. Oncologist. 14:43–56. 2009.PubMed/NCBI View Article : Google Scholar
10	Antonuzzo A, Lucchesi M, Brunetti IM, Galli L, Vasile E, Bonci F, Ricci S and Falcone A: Supportive care and not only palliative care in the route of cancer patients. Support Care Cancer. 21:657–658. 2013.PubMed/NCBI View Article : Google Scholar
11	Harper P and Littlewood T: Anaemia of cancer: Impact on patient fatigue and long term outcome. Oncology. 69:2–7. 2005.PubMed/NCBI View Article : Google Scholar
12	Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K and Morrow GR: Mechanisms of cancer-related fatigue. Oncologist. 12:22–34. 2007.PubMed/NCBI View Article : Google Scholar
13	Caro JJ, Salas M, Ward A and Goss G: Anemia as an independent prognostic factor for survival in patients with cancer: A systematic, quantitative review. Cancer. 91:2214–2221. 2001.PubMed/NCBI
14	Ripamonti CI, Molani P, Desti C, Boscagli G, Ravagnani F, Arienti F and Di Cristo C: A supportive care in cancer unit reduces costs and hospitalizations for transfusions in a comprehensive cancer center. Tumori. 18:449–456. 2017.PubMed/NCBI View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Clinical and economic effect of administration of red blood product transfusions in an outpatient supportive care cancer service

This article is mentioned in:

Abstract

Related Articles